Antitumour activity of 1,1-bis-(pyrimidine-2,4-diono-1-il)-2-bromo-2-chloroethylenes substituted molecular complexes and bacterial lectin

• Main Author: E. V. Welchinska (Author)
• Format: Book
• Published: Zaporozhye State Medical University, 2015-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Summary

The aim of research. One of the most successful directions of new antitumour preparations finding is the investigation of antimetabolites of pyrimidin's and purin's change which forwards as preformed compounds at the link of biosynthetic processes (DNA, RNA, specific proteins) and brakes tumour's growth. Molecular complexes on the base of 1,1-bis-[pyrimidine-2',4'-diono-1'-il]-2-bromo-2'-chloroethylenes and bacterial lectin Bacillus polymyxa were produced with the purpose of new potential antitumour preparation's obtaining. A purpose of the work is explaining of preformed heterocycles as pyrimidines, investigation of its antitumour activity. Molecular complexes of 1,1-bis-[pyrimidine-2',4'-diono-1'-il]-2-bromo-2'-chloroethylenes and bacterial lectin Bacillus polymyxa were received. Materials and methods. Objects of investigations are new bis-derivatives which were synthesised on the base of substituted pyrimidines and halothane. Investigation of critical toxicity of new compounds was carried out at Institute of Pharmacology and Toxicology of National Academy of Medical Sciences of Ukraine. The lectin's preparations were obtained by treatment of culture Liquid of saprophytic strain Bacillus from Ukrainian Collection of Microorganisms of Institute of Microbiology and Virology (IMV): B. polymyxa 102 KGU; in future: lectine 102) clarified by treatment with ammonium sulfate (70% concentration of a saturated solution). The white imbredical mice and experimental model of tumor growth-cancer Limphosarcoma Plisa, published in Prozorovskiy (1978), were used. The experimental tumors used for our investigation were obtained from Strain Bank of Oncological Centre of Russian Academy of Medical Sciences. The experimental tumors were used for passage on experimental animals, and program freezing. Afterward, these would be preserved in Strain Bank of Institute of Pharmacology and Toxicology of National Academy of Medical Sciences of Ukraine. The quantity of animals in each group was six. Minimum weight of mice body was 17.0±2.0 g and 22,0±2,0 g, of rats body was 160,0+20,0 g. Percentage of primary recovery and destruction is "0." Method of killing was decapitation and ethyl ester overdose. The method of the experimental tumors removal was surgery. There were six introductions of the physiological solutions of molecular complexes every day. The dosage of the preparations corresponded to 1/4-1/6 of the LD50. The efficiency parameter (% of tumor growth relaxation [volume and mass]) is > 50% in case of cancer Limphosarcoma Plisa. The main control data are: average weight of the tumor in the control animals (g), average weight of the tumor in experimental animals (g), % of growth relaxation of the tumor, index of effectiveness, and spleen ratio. The considerable criterion is > 50.0% of growth relaxation of the tumor. Preparation of standard was 5-flurouracil (5-FU). The results were assessed by standard methods of statistical analysis. Molecular complex of bis-adduct and bacterial lectin was obtained by mixing two components at physiological solution, 1:1. Results. It was discovered that molecular complexes of bis-derivatives of pyrimidines and bacterial lectin apply little toxic preparations (LD50: from 338 mg/kg to 335 mg/kg). It has been established that molecular complexes of Bacillus polymyxa 102 KGU and bis-derivatives shows an anti-tumor activity on cancer Lymphosarcoma Plisa: 62,5% - 62.8% growth braking in cancer growth (considerable criteria is > 50.0% of tumor growth relaxation). Conclusion. Anti-tumor activity of molecular complexes of Bacillus polymyxa 102 KGU and bis-derivative of pyrimidines permits us to consider it as physiological active with a perspective investigation as a potential antitumor drug for future treatment in people. The construction of the principle of new medical preparations, on the basis of the saprophytic strains bacterial lectins and heterocyclic bis-adducts, is very possible.

Item Description

10.14739/2409-2932.2015.1.41341
2306-8094
2409-2932